Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes,Gene_set
Sulfur metabolism_Homo sapiens_hsa00920,1/10,0.02472594881725805,1.0,0,0,40.0,147.99608109585552,ETHE1,KEGG_2016
MicroRNAs in cancer_Homo sapiens_hsa05206,3/297,0.038072480680894506,1.0,0,0,4.040404040404041,13.205105251183632,ZEB2;IRS1;ERBB2,KEGG_2016
Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770,1/18,0.044074494931692666,1.0,0,0,22.222222222222218,69.37497800124764,COASY,KEGG_2016
Hippo signaling pathway_Homo sapiens_hsa04390,2/153,0.05609600597575077,1.0,0,0,5.2287581699346415,15.062434842960007,FRMD6;CTGF,KEGG_2016
Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760,1/29,0.07006575883720892,1.0,0,0,13.79310344827586,36.66649746129542,NT5C3A,KEGG_2016
Purine metabolism_Homo sapiens_hsa00230,2/176,0.07167932615047057,1.0,0,0,4.545454545454546,11.979785959828348,NT5C3A;AK1,KEGG_2016
Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960,1/39,0.09309240170465724,1.0,0,0,10.256410256410255,24.350386793567683,IRS1,KEGG_2016
Bladder cancer_Homo sapiens_hsa05219,1/41,0.09763021468476817,1.0,0,0,9.75609756097561,22.69822689545236,ERBB2,KEGG_2016
Type II diabetes mellitus_Homo sapiens_hsa04930,1/48,0.11333801483691312,1.0,0,0,8.333333333333332,18.14483869590532,IRS1,KEGG_2016
Endometrial cancer_Homo sapiens_hsa05213,1/52,0.12219326087078625,1.0,0,0,7.6923076923076925,16.170395247094408,ERBB2,KEGG_2016
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923,1/56,0.13096181981447472,1.0,0,0,7.142857142857142,14.5203532147087,IRS1,KEGG_2016
Non-small cell lung cancer_Homo sapiens_hsa05223,1/56,0.13096181981447472,1.0,0,0,7.142857142857142,14.5203532147087,ERBB2,KEGG_2016
mTOR signaling pathway_Homo sapiens_hsa04150,1/60,0.13964452305344066,1.0,0,0,6.666666666666666,13.124368043030861,IRS1,KEGG_2016
Longevity regulating pathway - multiple species_Homo sapiens_hsa04213,1/64,0.14824219418025958,1.0,0,0,6.25,11.930674347342356,IRS1,KEGG_2016
Pancreatic cancer_Homo sapiens_hsa05212,1/66,0.15250939797562668,1.0,0,0,6.0606060606060606,11.397145810689672,ERBB2,KEGG_2016
Central carbon metabolism in cancer_Homo sapiens_hsa05230,1/67,0.15463513630999146,1.0,0,0,5.970149253731343,11.144399380722325,ERBB2,KEGG_2016
p53 signaling pathway_Homo sapiens_hsa04115,1/69,0.15887094888113906,1.0,0,0,5.797101449275362,10.664713325094516,CD82,KEGG_2016
Adipocytokine signaling pathway_Homo sapiens_hsa04920,1/70,0.16098104828531062,1.0,0,0,5.7142857142857135,10.436963619656767,IRS1,KEGG_2016
Adherens junction_Homo sapiens_hsa04520,1/74,0.16936969182663447,1.0,0,0,5.405405405405406,9.598223933017406,ERBB2,KEGG_2016
Peroxisome_Homo sapiens_hsa04146,1/83,0.18794476153579326,1.0,0,0,4.819277108433735,8.055938221418495,PHYH,KEGG_2016
ErbB signaling pathway_Homo sapiens_hsa04012,1/87,0.19606909758966404,1.0,0,0,4.597701149425287,7.490979968533419,ERBB2,KEGG_2016
Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008,1/89,0.20010134077429026,1.0,0,0,4.4943820224719095,7.231152075926772,REXO2,KEGG_2016
Prostate cancer_Homo sapiens_hsa05215,1/89,0.20010134077429026,1.0,0,0,4.4943820224719095,7.231152075926772,ERBB2,KEGG_2016
Longevity regulating pathway - mammal_Homo sapiens_hsa04211,1/94,0.2100954368002021,1.0,0,0,4.25531914893617,6.639120810840117,IRS1,KEGG_2016
HIF-1 signaling pathway_Homo sapiens_hsa04066,1/103,0.2277773453985499,1.0,0,0,3.883495145631068,5.745190999759117,ERBB2,KEGG_2016
Pyrimidine metabolism_Homo sapiens_hsa00240,1/105,0.23165366154685366,1.0,0,0,3.8095238095238098,5.571473755691552,NT5C3A,KEGG_2016
Insulin resistance_Homo sapiens_hsa04931,1/109,0.23934917373986106,1.0,0,0,3.669724770642202,5.24708923027374,IRS1,KEGG_2016
Neurotrophin signaling pathway_Homo sapiens_hsa04722,1/120,0.26012446216628154,1.0,0,0,3.333333333333333,4.488650206225545,IRS1,KEGG_2016
AMPK signaling pathway_Homo sapiens_hsa04152,1/124,0.2675403902734135,1.0,0,0,3.2258064516129035,4.253176556025354,IRS1,KEGG_2016
FoxO signaling pathway_Homo sapiens_hsa04068,1/133,0.28396090387727224,1.0,0,0,3.0075187969924815,3.7862216923345575,IRS1,KEGG_2016
Insulin signaling pathway_Homo sapiens_hsa04910,1/139,0.2947069182263765,1.0,0,0,2.8776978417266186,3.515896155469985,IRS1,KEGG_2016
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932,1/151,0.3157269440683073,1.0,0,0,2.649006622516556,3.053980238398419,IRS1,KEGG_2016
Jak-STAT signaling pathway_Homo sapiens_hsa04630,1/158,0.3277037968552589,1.0,0,0,2.531645569620253,2.8244180682758646,CTF1,KEGG_2016
cGMP-PKG signaling pathway_Homo sapiens_hsa04022,1/167,0.34280111726084433,1.0,0,0,2.395209580838324,2.5643229533967844,IRS1,KEGG_2016
Calcium signaling pathway_Homo sapiens_hsa04020,1/180,0.3640234091355428,1.0,0,0,2.2222222222222223,2.2456380057807053,ERBB2,KEGG_2016
Huntington's disease_Homo sapiens_hsa05016,1/193,0.38457365959084777,1.0,0,0,2.0725388601036268,1.9805594528003363,DNALI1,KEGG_2016
Focal adhesion_Homo sapiens_hsa04510,1/202,0.39841806759200604,1.0,0,0,1.98019801980198,1.8222839681553469,ERBB2,KEGG_2016
Proteoglycans in cancer_Homo sapiens_hsa05205,1/203,0.3999373645428959,1.0,0,0,1.9704433497536944,1.8058075522723092,ERBB2,KEGG_2016
Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060,1/265,0.4871391593898299,1.0,0,0,1.5094339622641508,1.085593129787262,CTF1,KEGG_2016
PI3K-Akt signaling pathway_Homo sapiens_hsa04151,1/341,0.5772243543740008,1.0,0,0,1.1730205278592376,0.6446032363371408,IRS1,KEGG_2016
Metabolic pathways_Homo sapiens_hsa01100,3/1239,0.6061993815055021,1.0,0,0,0.9685230024213076,0.4847906388767185,NT5C3A;AK1;COASY,KEGG_2016
Pathways in cancer_Homo sapiens_hsa05200,1/397,0.6334876747200344,1.0,0,0,1.0075566750629723,0.4599644687744256,ERBB2,KEGG_2016
